about
Tolerability and safety of ropinirole versus other dopamine agonists and levodopa in the treatment of Parkinson's disease: meta-analysis of randomized controlled trialsNormative Data for the Spanish Version of the Addenbrooke's Cognitive Examination III.Detection of genomic rearrangements from targeted resequencing data in Parkinson's disease patientsBrain apparent water diffusion coefficient magnetic resonance image during a prolonged visual aura.Rivastigmine for dementia associated with Parkinson's disease.Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease.Diagnosis and management of essential tremor and dystonic tremor.Repetitive transcranial magnetic stimulation for the treatment of depression. Systematic review and meta-analysis.Therapeutic development paths for cognitive impairment in Parkinson's disease: report of a regulatory roundtableMDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI.Hallucinations and sleep disturbances in Parkinson's disease.COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progDiagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines.Selecting deep brain stimulation or infusion therapies in advanced Parkinson's disease: an evidence-based reviewIndividual triptan selection in migraine attack therapy.Cognitive impairment in Parkinson's disease: tools for diagnosis and assessment.Is all cognitive impairment in Parkinson's disease "mild cognitive impairment"?Adenosine A2A-receptor antagonism and pathophysiology of Parkinson's disease and drug-induced movement disorders.Cognitive impairment in nondemented Parkinson's disease.Cognitive impairment and dementia in Parkinson's disease.Parkinson's disease: from genetics to clinical practice.The tools of the trade: a state of the art "How to Assess Cognition" in the patient with Parkinson's disease.Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial.Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia.Preclinical memory profile in Alzheimer patients with and without allele APOE-epsilon4.Semantic knowledge of famous people in mild cognitive impairment and progression to Alzheimer's disease.Effects of pallidotomy and bilateral subthalamic stimulation on cognitive function in Parkinson disease. A controlled comparative study.Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment.Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity.Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging.Efficacy of botulinum toxin in severe Tourette syndrome with dystonic tics involving the neck.Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease.Copy number variation analysis of the 17q21.31 region and its role in neurodegenerative diseases.Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.Rotigotine transdermal patch and sleep in Parkinson's disease: where are we now?Facial emotion recognition impairment in patients with Parkinson's disease and isolated apathy.Melevodopa/carbidopa effervescent formulation in the treatment of motor fluctuations in advanced Parkinson's disease.MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: Results from the Dementia Genetics Spanish Consortium.Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.Dementia risk in Parkinson disease: disentangling the role of MAPT haplotypes.
P50
Q28270780-11E497A4-0424-4A99-A513-24BA0DE6F499Q31103993-C42428FB-26F4-41AC-9A45-AAD56A434EB0Q31156952-9C5A6676-64E2-44C1-93F0-B2FAC6FEED21Q33561139-C60B3570-4A1F-47A1-BECF-6F4CDDBD80CCQ33983707-D56E020E-B9F2-4908-9088-2A44EF9B6D03Q34566376-ADB06BE0-9EEE-4A0A-AA9C-8B6B7AD7C2F0Q34625978-9017459B-AA0A-4904-AF21-3797445B4CBFQ35141247-5D9B36E8-3486-4680-9F5B-55D6C8D42C36Q35211545-2A4F3AA7-7377-4D85-A82E-FF823D77317BQ35234522-6C38EF4E-EA2E-41A2-879D-42C0DD522002Q35927814-6F4B8703-82AA-4E6B-BFFC-590D6E86E30BQ36616565-F917DEAB-9B17-4D02-AF7B-678670B6636EQ36810589-A706AA41-7572-4830-9F59-794A96548777Q37302240-11B259CF-F778-406E-BFD7-B5A6C8912BCEQ37370700-25AA60D2-90DE-4D14-A62B-C08B4C147810Q37437501-A2BA4EBD-FBE2-4007-A7A8-22146303A27EQ37892977-02911161-3A0B-4209-90C1-30C9FAEB997BQ37963718-6821FEBF-B7C4-40E3-A175-DA17128ACB01Q37968511-76E18ACD-E970-4A7C-8509-985132048387Q38000898-4BD5DE5D-4086-40E1-8382-700088F8ACF7Q38188556-4227FA2F-AC83-4222-A16A-2B2AC3C7FD7BQ38206495-1B3BDF34-A4E8-40A2-A018-1F63926DF5FFQ38383616-0262636F-A47E-4416-AECD-FB0F872066ABQ38387848-80BD466C-72F0-49BD-8D80-28B39F6A7D71Q38421941-246FA3B6-3FF5-49EB-B8F0-29ED41F92199Q38424103-A1523F78-8CC7-46B1-990A-B148DBD71C83Q38426804-BD9FC7ED-9C99-48D0-AF02-9D081A2A6E39Q38431646-A1401278-43FE-46BD-943A-7E4939D5B85CQ38451682-0AA56D03-68ED-47CC-BBBA-F74CA2C6CE12Q39219544-0B3FF53A-0BDC-4741-B105-AD85B23BCDBDQ39322545-4F439B9C-0A0F-467B-AEB3-13393FE99344Q39980895-DB391A6D-6739-4465-B80D-4FDB1ADDD988Q40321087-6CE7EFBA-C400-4FFA-960F-F87934685E3BQ40499334-8D65EDDF-D07F-4644-9A23-D0B7B6CA5591Q41620763-0FEE4CDB-7DF0-4E74-AF40-2D7EA6651DE6Q42408193-20B7E4C5-D80B-4D9B-A0C9-23A6B08A2186Q42952843-B19102E0-F3AD-40AC-AC38-33005D038FFAQ43339552-E5A3D00F-97E4-419D-83DE-C63A0D1C48A6Q43954098-3729D034-C09B-4226-AD6F-302BFE4231C5Q44559507-18D4A490-A965-4659-A79E-5169176D041D
P50
description
onderzoeker
@nl
name
Jaime Kulisevsky
@ast
Jaime Kulisevsky
@en
Jaime Kulisevsky
@es
Jaime Kulisevsky
@nl
type
label
Jaime Kulisevsky
@ast
Jaime Kulisevsky
@en
Jaime Kulisevsky
@es
Jaime Kulisevsky
@nl
altLabel
J Kulisevsky
@en
J. Kulisevsky
@en
Kulisevsky J
@en
Kulisevsky J.
@en
Kulisevsky
@en
prefLabel
Jaime Kulisevsky
@ast
Jaime Kulisevsky
@en
Jaime Kulisevsky
@es
Jaime Kulisevsky
@nl